A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome.

Clinical trial NCT06788431 · RECRUITING

Trial details

NCT number: NCT06788431
Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2025-03-10
Primary completion: 2026-10-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.